$0.60
+0.07 (+13.99%)
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+523.5% upside
Low Target
$2.62
Average Target
$3.76
High Target
$5.13
Current Price
$0.60
Current
$0.60
$0.60
Target
$3.76
$3.76
$2.62
$3.76 avg
$5.13
Scenario Analysis
Bear Case
$2.62
334.5%
Low target
Base Case
$3.76
+523.5%
Avg target
Bull Case
$5.13
+750.7%
High target
Risk/Reward
2.2x
Favorable
Price in Context
52-Week High
$4.33
-86.1% from high
52-Week Low
$0.38
+58.6% from low
Target vs 52W High
$3.76
-13.2% vs high
Next Earnings Report
Apr 17, 2026
15d
until earnings
EPS Est: $-0.10
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Buy | 39 | 69% | $257.58 | +18.4% |
| AMGN | Hold | 42 | 50% | $190.87 | -45.8% |
| GILD | Strong Buy | 38 | 79% | $362.68 | +160.2% |
| VRTX | Strong Buy | 39 | 79% | $438.34 | -1.8% |
| REGN | Strong Buy | 36 | 75% | $76.80 | -90.1% |
| ALNY | Strong Buy | 36 | 78% | $102.31 | -69.1% |
| INSM | Strong Buy | 26 | 92% | $143.40 | -12.3% |
| NTRA | Strong Buy | 27 | 89% | $142.91 | -28.5% |